We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors to Know Ahead of TreeHouse Foods' (THS) Q1 Earnings
Read MoreHide Full Article
TreeHouse Foods, Inc. (THS - Free Report) is scheduled to release first-quarter 2020 results on May 7. The company delivered a positive earnings surprise of 0.9% in the last reported quarter. Further, it has outperformed the Zacks Consensus Estimate by 9.1%, on average, in the trailing four quarters.
The Zacks Consensus Estimate for first-quarter earnings has gone up by 10.3% in the past seven days to 32 cents per share. This also suggests a substantial increase from 13 cents reported in the year-ago quarter. However, the consensus mark for revenues stands at $1,047 million, indicating a decline of 19.6% from the year-ago period’s reported figure.
TreeHouse Foods has been seeing a drab sales trend for a while now, partly due to SKU rationalization efforts and adverse volume/mix. Also, foreign currency headwinds have been a concern. We note that the company has been particularly struggling with sluggish Baked Goods and Meal Solutions units. Incidentally, the company recently informed that it will reorganize itself into two segments on the basis of market dynamics (Snacking & Beverages, and Meal Preparation) effective first-quarter 2020.
In the last earnings call, management said that it expects a 3-5% decline in net sales in the first half of 2020, which raises concerns over the quarter under review. For the first quarter, management projected net sales in a band of $0.98-$1.02 billion.
Nevertheless, focus on healthy and organic product offerings bodes well. Also, TreeHouse Foods’ restructuring initiatives have been yielding favorably. To this end, the company has been benefiting from its Structure to Win program, which focuses on aligning SG&A expenses with its division structures. Moreover, the company has been on track with its TreeHouse 2020 strategic plan. Alongside cost savings, the initiative has been helping the company manage the portfolio and optimize production and supply chain. The plan was aimed at improving the company’s operating margin by 300 bps by the end of 2020 through complete business integration and expense reduction.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for TreeHouse Foods this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Here are some more companies you may want to consider, as our model shows that these too have the right combination of elements to post an earnings beat.
Hain Celestial (HAIN - Free Report) has an Earnings ESP of +9.24% and a Zacks Rank #1.
Smucker (SJM - Free Report) has an Earnings ESP of +1.65% and a Zacks Rank #1.
Flowers Foods (FLO - Free Report) has an Earnings ESP of +7.77% and a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Factors to Know Ahead of TreeHouse Foods' (THS) Q1 Earnings
TreeHouse Foods, Inc. (THS - Free Report) is scheduled to release first-quarter 2020 results on May 7. The company delivered a positive earnings surprise of 0.9% in the last reported quarter. Further, it has outperformed the Zacks Consensus Estimate by 9.1%, on average, in the trailing four quarters.
The Zacks Consensus Estimate for first-quarter earnings has gone up by 10.3% in the past seven days to 32 cents per share. This also suggests a substantial increase from 13 cents reported in the year-ago quarter. However, the consensus mark for revenues stands at $1,047 million, indicating a decline of 19.6% from the year-ago period’s reported figure.
TreeHouse Foods, Inc. Price and EPS Surprise
TreeHouse Foods, Inc. price-eps-surprise | TreeHouse Foods, Inc. Quote
Key Factors to Note
TreeHouse Foods has been seeing a drab sales trend for a while now, partly due to SKU rationalization efforts and adverse volume/mix. Also, foreign currency headwinds have been a concern. We note that the company has been particularly struggling with sluggish Baked Goods and Meal Solutions units. Incidentally, the company recently informed that it will reorganize itself into two segments on the basis of market dynamics (Snacking & Beverages, and Meal Preparation) effective first-quarter 2020.
In the last earnings call, management said that it expects a 3-5% decline in net sales in the first half of 2020, which raises concerns over the quarter under review. For the first quarter, management projected net sales in a band of $0.98-$1.02 billion.
Nevertheless, focus on healthy and organic product offerings bodes well. Also, TreeHouse Foods’ restructuring initiatives have been yielding favorably. To this end, the company has been benefiting from its Structure to Win program, which focuses on aligning SG&A expenses with its division structures. Moreover, the company has been on track with its TreeHouse 2020 strategic plan. Alongside cost savings, the initiative has been helping the company manage the portfolio and optimize production and supply chain. The plan was aimed at improving the company’s operating margin by 300 bps by the end of 2020 through complete business integration and expense reduction.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for TreeHouse Foods this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
TreeHouse Foods carries a Zacks Rank #3 and an Earnings ESP of +25.00%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Other Stocks With Favorable Combinations
Here are some more companies you may want to consider, as our model shows that these too have the right combination of elements to post an earnings beat.
Hain Celestial (HAIN - Free Report) has an Earnings ESP of +9.24% and a Zacks Rank #1.
Smucker (SJM - Free Report) has an Earnings ESP of +1.65% and a Zacks Rank #1.
Flowers Foods (FLO - Free Report) has an Earnings ESP of +7.77% and a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>